Revenue
2018
2019
2020
2021
2022
2023
2024
2025
iBio, Inc. (IBIO)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $400,000 | $225,000 | $0 | $1.9M | $2.4M | $0 | $37,000 | $44,000 | $394,000 | $948,000 | $1.9M | $205,000 | $1.0M | $1.3M | $520,080 |
| Gross profit | — | — | — | $2.2M | $909,000 | $935,000 | — | — | — | — | — | — | — | — | — |
| Research & development | $8.3M | $5.2M | $10.3M | $9.8M | $10.0M | $3.6M | $5.5M | $4.0M | $4.1M | $3.2M | $3.5M | $1.9M | $3.4M | $5.0M | $3.1M |
| Operating expenses | $19.0M | $16.9M | $29.3M | $31.6M | $32.0M | $14.9M | $17.8M | $14.7M | $14.7M | $10.8M | $8.5M | $4.0M | $7.7M | $10.6M | $10.2M |
| Operating income | −$18.6M | −$16.6M | −$29.3M | −$29.7M | −$31.1M | −$14.0M | −$15.8M | −$14.2M | −$14.3M | −$9.9M | −$6.7M | −$3.8M | −$6.7M | −$9.3M | −$9.7M |
| EBITDAderived | −$18.1M | −$16.0M | −$28.5M | −$27.0M | −$30.3M | −$13.4M | −$15.6M | −$12.5M | −$12.6M | −$9.0M | −$6.3M | −$3.5M | −$6.3M | −$9.0M | −$9.3M |
| Net income | −$18.4M | −$24.9M | −$65.0M | −$50.3M | −$23.2M | −$16.4M | −$17.6M | −$16.1M | −$14.5M | −$9.8M | −$6.6M | −$3.7M | −$6.2M | −$5.7M | −$12.1M |
| Basic EPSper diluted share | -$1.75 | -$6.50 | -$106.19 | -$5.78 | -$3.00 | -$0.61 | -$0.94 | -$1.54 | -$1.64 | -$0.12 | -$0.09 | -$0.06 | -$0.13 | -$0.14 | -$0.39 |
| Diluted EPSper diluted share | -$1.75 | -$6.50 | -$106.19 | -$5.78 | -$3.00 | -$0.61 | -$0.94 | -$1.54 | -$1.64 | -$0.12 | -$0.09 | -$0.06 | -$0.13 | -$0.14 | -$0.39 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 26, 2026Form 4 | Banjak MarcChief Legal Officer | BuyCommon Stock | 1.4K | $1.76 | $2.5K | 25.0K |
| Mar 26, 2026Form 4 | Banjak MarcChief Legal Officer | BuyCommon Stock | 12.5K | $1.64 | $20.5K | 23.6K |
| Mar 19, 2026Form 4 | Duran FelipeChief Financial Officer | BuyCommon Stock | 24.8K | $2.02 | $50.2K | 36.0K |
| Mar 19, 2026Form 4 | Brenner MartinSee Remarks | BuyCommon Stock | 12.3K | $2.02 | $24.9K | 30.7K |
| Jan 10, 2025Form 4 | Duran FelipeChief Financial Officer | BuyCommon Stock | 9.2K | $2.72 | $25.0K | 11.1K |